Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eisai Co. Ltd.
4523Current price
5 075 JPY
-23.15 JPY (-0.45%)
Last closed
5 178 JPY
Company
www.eisai.co.jp
ISIN
JP3160400002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Tokyo Stock Exchange
Capitalization
1 430 759 061 944 JPY
Yield for 12 month
-37.90 %
1Y
3Y
5Y
10Y
15Y
4523
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Address: 4-6-10, Koishikawa, Tokyo, Japan, 112-8088
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 197 239.97 JPYP/E ratio
44.6429Dividend Yield
3.26 %Current Year
+741 411 692 284 JPY
Last Year
+744 061 479 503 JPY
Current Quarter
+188 942 530 319 JPY
Last Quarter
+190 408 859 276 JPY
Current Year
+563 516 106 336 JPY
Last Year
+566 305 829 638 JPY
Current Quarter
+149 203 716 831 JPY
Last Quarter
+154 319 375 578 JPY
Key Figures 4523
1 year
3 years
5 years
10 years
EBITDA
71 400 326 567 JPY
Operating Margin TTM
PE Ratio
44.6429
Return On Assets TTM
1.46 %
PEG Ratio
–
Return On Equity TTM
3.85 %
Wall Street Target Price
1 197 239.97 JPY
Revenue TTM
733 509 304 871 JPY
Book Value
3 135.85 JPY
Revenue Per Share TTM
Dividend Share
159.93 JPY
Quarterly Revenue Growth YOY
-4 %
Dividend Yield
3.26 %
Gross Profit TTM
566 305 829 603 JPY
Earnings per share
113.63 JPY
Diluted Eps TTM
113.63 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-47.9 %
Profit Margin
4.45 %
Dividend Analytics 4523
Dividend growth over 5 years
7 %Continuous growth
1 yearPayout Ratio 5 years average
42 %Dividend History 4523
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
160
Ex Dividend Date
28.03.2025
Forward Annual Dividend Yield
3.15 %
Last Split Factor
–
Payout Ratio
2.38 %
Last Split Date
–
Dividend Date
–
Stock Valuation 4523
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
44.6429
Forward PE
32.6797
Enterprise Value Revenue
1.752
Price Sales TTM
1.9506
Enterprise Value EBITDA
14.0078
Price Book MRQ
1.6348
Financials 4523
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4523
For 52 weeks
4 911.96 JPY
8 042.43 JPY
50 Day MA
5 602.82 JPY
Shares Short Prior Month
–
200 Day MA
6 205.99 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart